Showing results (1-10 of 203) with videos related to
Sort By:
Pageof 21
The Annals of Pharmacotherapy|March 17, 2005
Outcomes of Project Dulce: a culturally specific diabetes management programTodd P Gilmer, Athena Philis-Tsimikas, Chris WalkerDiabetes Care|March 22, 2008
Improving treatment of depression among Latinos with diabetes using project Dulce and IMPACTTodd P Gilmer, Chris Walker, Elizabeth D Johnson, et al.American Journal of Therapeutics|November 24, 2006
Glycemic control with insulin glargine as part of an ethnically diverse, community-based diabetes management programAthena Philis-Tsimikas, Quanwu Zhang, Chris WalkerThe Journal of Family Practice|November 16, 2016
An Evolutionary Perspective on Basal Insulin in Diabetes Treatment: Innovations in Insulin: Insulin Degludec U-100 and U-200Athena Philis-TsimikasPatient Preference and Adherence|November 19, 2009
Tolerability, safety and adherence to treatment with insulin detemir injection in the treatment of type 2 diabetesAthena Philis-TsimikasExpert Opinion on Pharmacotherapy|August 2, 2008
An update on the use of insulin detemir, with a focus on type 2 diabetes (drug evaluation update)Athena Philis-TsimikasThe American Journal of Medicine|August 20, 2013
Initiating basal insulin therapy in type 2 diabetes: practical steps to optimize glycemic controlAthena Philis-TsimikasRevista Panamericana De Salud Publica = Pan American Journal of Public Health|October 22, 2010
Support for disease management, depression, self-care, and clinical indicators among Hispanics with type 2 diabetes in San Diego County, United States of AmericaAddie L Fortmann, Linda C Gallo, Chris Walker, et al.Diabetes Care|July 22, 2011
Peer-led diabetes education programs in high-risk Mexican Americans improve glycemic control compared with standard approaches: a Project Dulce promotora randomized trialAthena Philis-Tsimikas, Adelaide Fortmann, Leticia Lleva-Ocana, et al.Pharmacotherapy|October 18, 2013
A new option for glycemic control: insulin degludec, a new-generation basal insulin with an ultralong duration of actionScott R Drab, Athena Philis-TsimikasPageof 21